Anti-UGCG monoclonal antibody
Pre-made anti-UGCG monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to UGCG/UGCG products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP0022-Ab-1/ GM-Tg-hg-IP0022-Ab-2 | Anti-Human UGCG monoclonal antibody | Human |
GM-Tg-rg-IP0022-Ab-1/ GM-Tg-rg-IP0022-Ab-2 | Anti-Rat UGCG monoclonal antibody | Rat |
GM-Tg-mg-IP0022-Ab-1/ GM-Tg-mg-IP0022-Ab-2 | Anti-Mouse UGCG monoclonal antibody | Mouse |
GM-Tg-cynog-IP0022-Ab-1/ GM-Tg-cynog-IP0022-Ab-2 | Anti-Cynomolgus/ Rhesus macaque UGCG monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP0022-Ab-1/ GM-Tg-felg-IP0022-Ab-2 | Anti-Feline UGCG monoclonal antibody | Feline |
GM-Tg-cang-IP0022-Ab-1/ GM-Tg-cang-IP0022-Ab-2 | Anti-Canine UGCG monoclonal antibody | Canine |
GM-Tg-bovg-IP0022-Ab-1/ GM-Tg-bovg-IP0022-Ab-2 | Anti-Bovine UGCG monoclonal antibody | Bovine |
GM-Tg-equg-IP0022-Ab-1/ GM-Tg-equg-IP0022-Ab-2 | Anti-Equine UGCG monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP0022-Ab-1/ GM-Tg-hg-IP0022-Ab-2; GM-Tg-rg-IP0022-Ab-1/ GM-Tg-rg-IP0022-Ab-2; GM-Tg-mg-IP0022-Ab-1/ GM-Tg-mg-IP0022-Ab-2; GM-Tg-cynog-IP0022-Ab-1/ GM-Tg-cynog-IP0022-Ab-2; GM-Tg-felg-IP0022-Ab-1/ GM-Tg-felg-IP0022-Ab-2; GM-Tg-cang-IP0022-Ab-1/ GM-Tg-cang-IP0022-Ab-2; GM-Tg-bovg-IP0022-Ab-1/ GM-Tg-bovg-IP0022-Ab-2; GM-Tg-equg-IP0022-Ab-1/ GM-Tg-equg-IP0022-Ab-2 |
Products Name | Anti-UGCG monoclonal antibody |
Format | mab |
Target Name | UGCG |
Protein Sub-location | Introcelluar Protein |
Category of antibody | Therapeutics Target antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-UGCG monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP0022-Ag-1 | Recombinant multi-species CEGT/ UGCG/ GCS protein |
ORF Viral Vector | vGMLP003640 | human UGCG Lentivirus particle |
ORF Viral Vector | pGMLP003640 | human UGCG Lentivirus plasmid |
ORF Viral Vector | pGMLPm002552 | mouse Ugcg Lentivirus plasmid |
ORF Viral Vector | vGMLPm002552 | mouse Ugcg Lentivirus particle |
Target information
Target ID | GM-IP0022 |
Target Name | UGCG |
Gene ID | 7357,22234,83626,707875,481666,101101006,514357,100057611 |
Gene Symbol and Synonyms | Epcs21,GCS,GlcT-1,GLCT1,UGCG,Ugcgl |
Uniprot Accession | Q16739,Q9R0E0 |
Uniprot Entry Name | CEGT_HUMAN,CEGT_RAT |
Protein Sub-location | Introcelluar Protein |
Category | Therapeutics Target |
Disease | N/A |
Gene Ensembl | ENSG00000148154 |
Target Classification | N/A |
The target: UGCG, gene name: UGCG, also named as GCS, GLCT1. This gene encodes an enzyme that catalyzes the first glycosylation step in the biosynthesis of glycosphingolipids, which are membrane components containing lipid and sugar moieties. The product of this reaction is glucosylceramide, which is the core structure of many glycosphingolipids. [provided by RefSeq, Dec 2014].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.